Innovating CAR T cell therapy for today and tomorrow

A new era has emerged in the cancer treatment landscape as cell therapies demonstrate their potential to be game changing. Inherent limitations of autologous CAR T cell therapies exist, which can restrict their application. Therefore, further exploration into engineered allogeneic CAR T cell therapy is needed as early research in hematologic cancers has demonstrated the potential of this powerful immunotherapy.

Please enter your email to access content Read now